Todo lo que necesita saber sobre las pruebas del COVID-19
Las pruebas y el rastreo generalizados son esenciales para controlar la propagación del COVID-19, pero hay varios tipos de pruebas diferentes, y cada una tiene un uso específico.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Dr. Iafrate is the director of the Center for Integrated Diagnostics, a clinical laboratory for molecular diagnostics at Massachusetts General Hospital. He oversees the Translational Research Laboratory (TRL), a shared effort of the Pathology Department and Mass General Cancer Center. The TRL provides rapid personalized genomic testing to help inform cancer treatment decisions for patients. Dr. Iafrate received his MD, PhD degrees from the State University of New York at Stony Brook in 2000, and was trained in anatomic and molecular genetic pathology at Brigham and Women's Hospital. He joined the Massachusetts General Hospital staff in 2005. His post-doctoral work involved the discovery and description of a novel source of human genetic diversity, termed "copy number variation" (CNV). He established a cancer diagnostics lab focusing on genetic fingerprints that help guide novel, targeted therapies. His laboratory launched SNaPshot several years ago, an assay that tests over 100 of the most common mutations in tumors. His research is focused on lung and brain tumors, and he has been closely involved in the clinical development of crizotinib and companion diagnostics in ALK-positive lung cancers.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Pathology Associates
55 Fruit Street
Boston, MA 02114-2696
Fax: 617-726-7474
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research in the Iafrate laboratory focuses on bringing new genetic technologies to cancer diagnostics and their application to the practice of pathology. Initially research focused on lung cancer, but our approach is expanding to all malignancies. For more information about research concepts, co-authors, and to see a timeline, visit Dr. Iafrate's profile at the Harvard Clinical and Translational Science Center.
View my most recent publications at PubMed
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
Las pruebas y el rastreo generalizados son esenciales para controlar la propagación del COVID-19, pero hay varios tipos de pruebas diferentes, y cada una tiene un uso específico.
John Iafrate, MD, PhD, y Edward Ryan, MD, desglosan los fundamentos sobre anticuerpos, pruebas de serología y las posibles implicaciones de una presencia positiva de anticuerpos en el caso del COVID-19.
John Iafrate, MD, PhD, and Edward Ryan, MD, break down the basics about antibodies, serology testing and the potential implications of a positive antibody presence in the case of COVID-19.